Charge Variant Analysis Market Report 2026

Charge Variant Analysis Market Overview

• Charge Variant Analysis market size has reached to $1.15 billion in 2025 • Expected to grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: The Growing Adoption Of Biosimilars The Growth Of The Market Due To Increasing Demand For Structurally And Functionally Comparable Biologics • Market Trend: Innovative Capillary Isoelectric Focusing Mass Spectrometry (Cief Ms) Platforms Enable High-Resolution Protein Therapeutic Profiling • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Charge Variant Analysis Market?

Charge variant analysis (CVA) is a technique used in biopharmaceutical development to identify and quantify different charged forms of a protein or antibody, which can arise from post-translational modifications, degradation, or manufacturing processes. It helps ensure product consistency, stability, and efficacy by monitoring these charge variants throughout development and production. The main techniques of charge variant analysis include ion exchange chromatography, capillary electrophoresis, isoelectric focusing, and others. Ion exchange chromatography is a separation technique that isolates molecules based on their net electrical charge by using a charged stationary phase to attract oppositely charged ions. The product types include instruments, consumables, software, and services. The key applications of biopharmaceuticals, research and development, quality control, and other applications, while the end-use includes pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end-users.

What Is The Charge Variant Analysis Market Growth Forecast?

The charge variant analysis market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to rising demand for automated cva systems, growing adoption of ai-enabled data analysis, expansion of biologics and biosimilars market, increasing focus on real-time monitoring of protein variants, integration of high-throughput analytical platforms. Major trends in the forecast period include increasing adoption of capillary electrophoresis techniques, rising demand for high-throughput ion exchange chromatography, growing integration of cva software for data analysis, expansion of analytical services for biopharmaceutical qa/qc, rising focus on multi-product and platform development.

Global Charge Variant Analysis Market Segmentation

1) By Technique: Ion Exchange Chromatography, Capillary Electrophoresis, Isoelectric Focusing, Other Techniques 2) By Product Type: Instruments, Consumables, Software, Services 3) By Application: Biopharmaceuticals, Research And Development, Quality Control, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users Subsegments: 1) By Ion Exchange Chromatography: Strong Cation Exchange, Weak Cation Exchange, Strong Anion Exchange, Weak Anion Exchange 2) By Capillary Electrophoresis: Capillary Zone Electrophoresis, Micellar Electrokinetic Chromatography, Capillary Gel Electrophoresis, Isoelectric Focusing Capillary Electrophoresis 3) By Isoelectric Focusing: Preparative Isoelectric Focusing, Analytical Isoelectric Focusing, Immobilized pH Gradient Isoelectric Focusing 4) By Other Techniques: High Performance Liquid Chromatography, Hydrophobic Interaction Chromatography, Affinity Chromatography, Mass Spectrometry Based Analysis

What Is The Driver Of The Charge Variant Analysis Market?

The growing adoption of biosimilars is expected to propel the growth of the charge variant analysis market going forward. Biosimilars are biologic medical products that are highly similar to an already approved reference biologic in terms of safety, efficacy, and quality but may have minor differences in clinically inactive components. The growing adoption of biosimilars is due to the expiration of patents on original biologic drugs, which allows manufacturers to produce lower-cost, clinically equivalent alternatives, increasing accessibility and competition in the market. Charge variant analysis helps biosimilars by ensuring their structural and functional comparability to the reference biologic, enabling accurate assessment of product quality, stability, and therapeutic consistency. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, the number of food and drug administration-approved biosimilar products in the U.S. increased from 33 in 2022, with 21 available on the market, to 40 in 2023, with 25 commercially available. Therefore, the growing adoption of biosimilars is driving the growth of the charge variant analysis industry.

Key Players In The Global Charge Variant Analysis Market

Major companies operating in the charge variant analysis market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, SGS Société Générale de Surveillance SA, Lonza Group AG, Agilent Technologies Inc., Creative Proteomics Inc., WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Sartorius AG, Shimadzu Corporation, Waters Corporation, Revvity Inc., Bio-Rad Laboratories Inc., Phenomenex Inc., Tosoh Bioscience LLC, JASCO Inc., Alturas Analytics Inc., BioPharmaSpec Inc., Eurofins Scientific SE.

Global Charge Variant Analysis Market Trends and Insights

Major companies operating in the charge variant analysis market are increasingly focusing on developing innovative analytical solutions, such as advanced capillary isoelectric focusing–mass spectrometry (cIEF-MS) platforms, to enable faster, more precise, and high-resolution characterization of protein therapeutics. Capillary isoelectric focusing–mass spectrometry is an analytical technique that separates proteins based on their isoelectric point and subsequently identifies and characterizes charge variants using mass spectrometry, allowing detailed and accurate profiling of protein heterogeneity.For instance, in June 2024, CMP Scientific Corp., a US-based biotechnology company, launched the BioSummit CVA System, an advanced cIEF-MS platform for online charge variant analysis. The system combines the company’s proprietary EMASS II CE-MS coupling technology with CR3520 cIEF-MS chemistry and a novel time-of-flight mass spectrometer to deliver high sensitivity, robustness, and seamless analytical workflows tailored for recombinant protein characterization. It enables high-resolution separation and identification of charge variants in a single integrated run, features streamlined reagent workflows, enhanced operational robustness, and comprehensive data analysis software, making it suitable for biopharmaceutical research, quality control, and regulatory support applications.

What Are Latest Mergers And Acquisitions In The Charge Variant Analysis Market?

In February 2026, CMP Scientific Corp., a US-based analytical technology company that provides advanced, high-resolution charge variant analysis (CVA) solutions, partnered with Eurofins BPT China Laboratory to deliver advanced CE MS services for biopharmaceutical characterization. This partnership aims to enhance charge variant analysis and overall protein therapeutic characterization by combining CMP Scientific’s expertise in capillary electrophoresis–mass spectrometry (CE MS) workflows with Eurofins BPT China Laboratory’s global analytical service capabilities. Eurofins BioPharma Product Testing (Shanghai) Co Ltd. is a China-based contract research organization specializing in analytical testing and biopharmaceutical development services.

Regional Insights

North America was the largest region in the charge variant analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Charge Variant Analysis Market?

The charge variant analysis market consists of revenues earned by entities by providing services such as protein charge profiling, capillary isoelectric focusing (CIEF) analysis, mass spectrometry-based characterization, method development and validation, and stability and comparability studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The charge variant analysis market also includes sales of analytical instruments, consumables, technique specific platforms, workflow kits and method packages, hardware accessories, and chromatography consumables and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Charge Variant Analysis Market Report 2026?

The charge variant analysis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the charge variant analysis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.